Product Information
SILVADENE 1% CREAM is a brand product labeled by Pfizer Inc., priced at $0.2308 per GM under NDC 61570013150. Its NADAC has been published 398 times since Jan 22, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Pfizer Inc.NDC
61570013150
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SILVER SULFADIAZINEApproval Type
New Drug (NDA)
FDA Application
NDA017381FDA Approved
Before 1982
TE Code
AB
On Market Since
11/26/1973
Pharmacological Classes
Price Statistics
The NADAC for SILVADENE 1% CREAM has been published 398 times since Jan 22, 2014, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2308 per GM |
|---|---|
| All-time high | $0.2797 (Apr 16, 2014) |
| All-time low | $0.1870 (May 17, 2023) |
| 52-week high | $0.2447 |
| 52-week low | $0.2265 |
| Median price | $0.2180 |
| Average price | $0.2255 |
| Largest weekly change | +21.7% (Sep 18, 2024) |
| Weeks tracked | 398 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
silver sulfadiazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILVADENE 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for SILVADENE 1% CREAM, manufactured by Pfizer Inc., is $0.2308 per GM (NDC 61570013150), effective Sep 30, 2026.
How has the price of SILVADENE 1% CREAM changed over time?
Over the history we have for it, the NADAC for SILVADENE 1% CREAM has declined 17.5%. It has been tracked across 398 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for SILVADENE 1% CREAM?
Since Jan 22, 2014, the NADAC for SILVADENE 1% CREAM has ranged from a low of $0.1870 (May 17, 2023) to a high of $0.2797 (Apr 16, 2014), with a median of $0.2180 per GM.
Are there cheaper alternatives to SILVADENE 1% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SILVADENE 1% CREAM, is $0.1247 per GM — about 46% below SILVADENE 1% CREAM.
Who manufactures SILVADENE 1% CREAM?
SILVADENE 1% CREAM (NDC 61570013150) is labeled by Pfizer Inc., and CMS classifies it as a brand product.